Cargando…
The Protective Effects of 2’-Fucosyllactose Against E. Coli O157 Infection Are Mediated by the Regulation of Gut Microbiota and the Inhibition of Pathogen Adhesion
As the richest component in human milk oligosaccharides (HMOs), 2’-fucosyllactose (2’-FL) can reduce the colonization of harmful microbiota in vivo, thus lowering the risk of infection; however, the mechanism for this is still unclear. In this study, a model of Escherichia coli O157 infection in hea...
Autores principales: | Wang, Yuanyifei, Zou, Yan, Wang, Jin, Ma, Hui, Zhang, Bowei, Wang, Shuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7282266/ https://www.ncbi.nlm.nih.gov/pubmed/32369957 http://dx.doi.org/10.3390/nu12051284 |
Ejemplares similares
-
Protection of Galacto-Oligosaccharide against E. coli O157 Colonization through Enhancing Gut Barrier Function and Modulating Gut Microbiota
por: Zou, Yan, et al.
Publicado: (2020) -
Tartary Buckwheat (Fagopyrum tataricum) Ameliorates Lipid Metabolism Disorders and Gut Microbiota Dysbiosis in High-Fat Diet-Fed Mice
por: Li, Ang, et al.
Publicado: (2022) -
Ameliorating Effects of Bifidobacterium longum subsp. infantis FB3-14 against High-Fat-Diet-Induced Obesity and Gut Microbiota Disorder
por: Kou, Ruixin, et al.
Publicado: (2023) -
Escherichia coli O157:H7 senses microbiota-produced riboflavin to increase its virulence in the gut
por: Liu, Bin, et al.
Publicado: (2022) -
Multi‐level metabolic engineering of Escherichia coli for high‐titer biosynthesis of 2′‐fucosyllactose and 3‐fucosyllactose
por: Li, Mengli, et al.
Publicado: (2022)